Nouvelles Eulerpool Bristol-Myers Squibb

Bristol-Myers Squibb Actualités des actions

Bristol-Myers Squibb est surveillé par de nombreux journalistes et investisseurs du monde entier. Nous regroupons ici les dernières actualités Bristol-Myers Squibb.

• 19 novembre ·

  Yahoo
  Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms
• 19 novembre ·

  SeekingAlpha
  Merck: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
• 18 novembre ·

  Yahoo
  EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer
• 17 novembre ·

  SeekingAlpha
  Bristol-Myers Squibb: Buy This Bargain Before It's Gone
• 17 novembre ·

  Yahoo
  Large Pension Doubled Palantir Stake, Bought Up Intel and CVS Stock
• 15 novembre ·

  MarketWatch
  Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors
• 15 novembre ·

  Fintel
  Wolfe Research Initiates Coverage of Bristol-Myers Squibb (BMY) with Peer Perform Recommendation
• 15 novembre ·

  Yahoo
  Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer
• 15 novembre ·

  Yahoo
  Bristol Myers Squibb Receives Positive CHMP Opinion for Repotrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer and Advanced NTRK-Positive Solid Tumors
• 15 novembre ·

  SeekingAlpha
  Fidelity Value Discovery Fund Q3 2024 Review